SPAC is on the map 

Luxembourg, 10 December 2021

Arendt advised Alvotech Holdings S.A. (“Alvotech”), a fully integrated specialty biopharmaceutical group focused on the development and manufacturing of high quality biosimilar medicines, on all Luxembourg law aspects of the agreement to enter into a business combination (de-SPACing) with Oaktree Acquisition Corp. II, a SPAC sponsored by an affiliate of Oaktree Capital Management, L.P., and on all Luxembourg law aspects of structuring the business combination.

The combined group is expected to have an implied initial enterprise value of approximately USD 2.25 billion, and will enable further investment in the Alvotech platform and portfolio, furthering the company’s mission of bringing cost-effective biosimilars to patients in all major markets around the globe.

With unparalleled expertise in SPACs and de-SPACing transactions in Luxembourg, Arendt is optimally positioned to advise on the structuring, set-up, listing and subsequent business combination of SPACs in Luxembourg.

Arendt team involved:


New CSSF Circular on UCI Administrators

the Commission de Surveillance du Secteur Financier issued a circular regarding the authorisation and organisation of entities acting as UCI administrator

Read More_

Rodrigo Delcourt named Head of the Paris office

He succeeds Gregory Beltrame, who is now back in our Luxembourg office.

Arendt advised the Acron Group in acquiring a shareholding in Wooden S.A., a firm construc...

an unparalleled conjunction of legal and technical expertise in real estate

Arendt & Medernach advised a committee of bondholders for the EUR 1 billion restructuring ...

Arendt & Medernach’s Commercial & Insolvency team advised a committee of bondholders, in the context of the EUR 1 billion debt and equity restructurin...

Arendt’s statement on the war in Ukraine

We strongly condemn the actions of the Russian government. Arendt stands in solidarity with the people of Ukraine and all those affected by the war.